
|
News and Events > NewsLetters > Monthly Newsletter: February 2007
University of Colorado Technology Transfer Office
Monthly Newsletter
Volume 3 ~ Issue 7 ~ February 2007
Today at the TTO
CU Executes Exclusive Option Agreement with AgriHouse Inc.
The TTO recently executed an exclusive option agreement with AgriHouse Inc. for intelligent leaf sensory technology. AgriHouse, a leading edge agri-biotechnology company headquartered in Berthoud, CO, is developing first-generation leaf sensors to measure and monitor plant moisture demands and other plant physiological sensing applications. These discrete sensory devices combine magnetic resistance radio frequency and infrared technology for plant intelligence enabling on-demand watering and alternatives to current technologies of soil-based moisture monitoring and aerial infrared imaging. The “Sg-1000™,” based on CU research, provides leaf sensor RFID signaling of field crops transmitted to a wi-fi; the watering system supplies only the water the plant needs to use. The invention is primarily applicable to water conservation and water cost reduction applications for irrigated land.
CU Technology Transfer Annual Award Winners Announced
The University of Colorado Technology Transfer Office held its 5th Annual Awards event on January 24. The event, held at the historic Tivoli Turnhalle, was attended by over 200 local business leaders and faculty inventors. After a presentation from Myogen founders Dr. Michael Bristow and Dr. J. William Freytag, awards were presented to inventors, companies, and others who demonstrate best practices in technology transfer. Thanks to w3w3.com for their media sponsorship; visit their site to view a photo album from the event and listen to interviews with the winning inventors. Also, view the event program here (PDF). Awards were given to:
- Anatoliy Glushchenko, New Inventor of the Year, Colorado Springs campus (Assistant Professor of Physics at the University of Colorado, Colorado Springs)
- Jeffrey Holt, New Inventor of the Year, UCDHSC (Vice Chair for Research and Todd Professor of Experimental Pathology at the University of Colorado, Denver and Health Sciences Center)
- James Goodrich, New Inventor of the Year, Boulder campus (Associate Professor of Chemistry and Biochemistry at the University of Colorado, Boulder)
- Zbigniew Celinski, Inventor of the Year, Colorado Springs campus (Professor of Physics at the University of Colorado, Colorado Springs)
- Robin Shandas, Inventor of the Year, UCDHSC (Professor of Mechanical Engineering at the University of Colorado, Boulder and Professor of Pediatrics, University of Colorado, Denver and Health Sciences Center)
- Robert Kutchta & Kathy Rowlen, Inventors of the Year, Boulder campus (Associate Professor of Chemistry and Biochemistry at the University of Colorado, Boulder and Professor of Chemistry and Biochemistry at the University of Colorado, Boulder, respectively)
- Richard Duke, Business Advisor of the Year (Founder of ApopLogic Pharmaceutics and GlobeImmune, Inc.)
- ALD NanoSolutions, Physical Sciences/Engineering/IT Company of the Year (Broomfield, CO)
- Kyle Lefkoff, Pinnacles Achievement Award (Boulder Ventures)
National Science Foundation Ranks CU Research Activity in the Top 10 Percent of Universities Nationwide
The University of Colorado announced February 1 that its three-university system has maintained its position in the top ten percent of universities in the United States in the latest rankings by the National Science Foundation (NSF) on federal and non-federal research expenditures. The university has maintained its top ten ranking for the last five years. It is also the top ranked public university in federally financed research in environmental sciences and the third ranked in federally financed research in physical sciences.
SBIR/STTR Solicitations
Researchers: the Department of Defense has recently put out its 2007 solicitations, viewable at http://www.dodsbir.net/solicitation/. STTR solicitations require companies to partner with University researchers. If any of the new solicitations are a good match for your research capabilities, contact Terry Boult (tboult@cs.uccs.edu) for assistance in identifying a small business who can submit the proposal with you. Terry Boult is a faculty member at UCCS; he provides this service through the Colorado Institute for Technology Transfer and Implementation (CITTI).
Spring Proof of Concept Investment (POCi) – Application Deadline April 6, 2007
The application deadline for the upcoming TTO Proof of Concept investment (POCi) round is April 6, 2007. The POCi program provides early stage “seed” investments to enable the further development and validation of promising CU technologies that are, or will become, the platform for a CU start-up company. POCi program investments are $100,000 each and are determined based on a competitive application process. POCi funds must be used primarily for applied research, prototype development and testing, and other technology-focused research and development activities directed toward establishing the commercial viability of the technology. Information about the POCi program, selection criteria, application requirements, and the application form are available at https://www.cusys.edu/techtransfer/proof/investments.html. For questions about the POCi program, contact Tom Smerdon, Director, New Business Development, at tom.smerdon@cu.edu or 303-735-0621.
Spring Proof of Concept Grant (POCg) – Application Deadline April 13, 2007
The POCg Spring 2007 grant round is underway and applications may be submitted to the TTO through Friday, April 13, 2007. This round of POC grants provides funds to enable the further development and validation of promising non-bioscience CU technologies that are, or will become, suitable for commercialization. (Note: bioscience-related projects will be considered for POC funding in Fall 2007.) For more information about the POCg, selection criteria, and application requirements, visit https://www.cusys.edu/techtransfer/proof/grants.html or contact your TTO case manager.
Legislative Update: Higher Education Research Fund
HB 1060 – Bioscience Research Grants passed its first challenge; passed through the House Finance Committee. The bill now heads to the House Appropriations Committee.
SB 097 – CU Health Sciences Center bill passed the Senate State, Veterans and Military Affairs Committee Monday, February 12. The bill is expected to be heard in Appropriations on Friday, February 16th.
SB 182 – Higher Education Competitive Federally Funded Research passed through the Senate Higher Education Committee and goes next to Appropriations.
CU Technology and Licensee Companies in the News
LabCorp and ARCA Discovery Partner for First Cardiovascular Personalized Medicine
Laboratory Corporation of America Holdings (LabCorp), one of the world's leading clinical trials and genetic testing laboratories, and ARCA Discovery, Inc., a privately-held biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovascular diseases, announced on February 13 an exclusive collaboration to develop a commercial genetic test to aid in prescribing bucindolol, a genetically-targeted heart failure drug in development by ARCA, a CU-based startup.
Allos Therapeutics Announces Closing of Common Stock Offering
On February 2 Westminster-based Allos Therapeutics, Inc. announced the closing of its underwritten offering of 9,000,000 shares of its common stock at a price of $6.00 per share. The company received net proceeds from the offering of approximately $50.5 million, after deducting underwriting commissions and offering expenses. The company, a CU licensee, plans to use the proceeds from the financing primarily for clinical and preclinical research and development of its product candidates, small molecule therapeutics for the treatment of cancer.
Unique Collaboration Funded To Develop Nanotechnology For Melanoma
A unique collaboration between electrical engineers, mechanical engineers and cancer researchers may be the perfect combination to improve diagnosis, treatment and follow-up of patients with melanoma. Researchers at the University of Colorado Cancer Center, the University of Colorado at Boulder and the University of Texas at Dallas have received funding to develop a mechanical system the size of a wristwatch that will display the presence or absence of genetic signals of melanoma. The $1.1 million grant, funded over the next four years, was awarded by the National Science Foundation.
CU-Boulder, NASA Research Team Use Satellite To Track Earth's Water
For the first time, scientists have used a space-borne instrument to track the origin and movements of water vapor throughout Earth's atmosphere, providing a new perspective on the dominant role Earth's water cycle plays in weather and climate. A team of scientists from the University of Colorado at Boulder and NASA's Jet Propulsion Laboratory in Pasadena, Calif., used the Tropospheric Emission Spectrometer on NASA's Aura satellite to gather data on "heavy" and "light" water vapor in order to retrace the history of water over oceans and continents, from ice and liquid to vapor and back again.
Replidyne and Forest Labs End Faropenem Collaboration
Replidyne, Inc. and Forest Laboratories, Inc. announced February 6 that they have ended a February 2006 collaboration for the commercialization of faropenem medoxomil (faropenem), a novel community antibiotic in late-stage clinical development. In October 2006, the FDA issued a non-approvable letter for faropenem, recommending further clinical studies for all indications including studies using a superiority design, more extensive microbiologic confirmation, and consideration of alternate dosing regimens. The FDA did not raise any safety concerns or chemistry, manufacturing or controls (CMC) issues related to the product. As a result of the termination, Replidyne will re-acquire all U.S. adult and pediatric rights previously granted to Forest.
Nanomaterials Lab at CU Helps Students, Businesses Focus on Smallest Details
The University of Colorado at Boulder is aiming to be at the cutting edge of the nanotechnology revolution by launching the Nanomaterials Characterization Facility, located in the Discovery Learning Center at CU-Boulder. The goal at the facility is to educate students and develop new technologies by attracting researchers from CU and other research institutions. It also serves as a lab for companies to conduct research using instruments they don't have the resources to buy. CU built the center using $1.53 million raised through a Defense Advanced Research Projects Agency grant, the National Institute of Standards and Technology and industrial sponsors.
People
CU-Boulder Professor Wins Energy Grant To Improve Gasification Systems
A University of Colorado at Boulder faculty member has received a $1.6M grant from the U.S. Department of Energy to help develop new technologies to improve the performance and economics of clean power generation systems. The grant received by Christine Hrenya, associate professor of chemical and biological engineering, is aligned with the goals of FutureGen, a 10-year project aimed at creating the world's first coal plant with near-zero emissions. "An exciting aspect of this project is that because the research is fundamental in nature, it can be applied to a variety of applications," Hrenya said. "Coal is the most abundant energy resource in the U.S. now, but the new technologies also will apply to alternative feedstocks such as biomass."
Daily Camera Q&A with Paul Jerde
Ideas have to start somewhere. And it's Paul Jerde's hope that fostering the entrepreneurism and business at the university level can turn those ideas into successful ventures. Jerde is the executive director of the Robert H. and Beverly A. Deming Center for Entrepreneurship at the University of Colorado's Leeds School of Business. In February, the Deming Center is co-hosting the second annual Sustainable Opportunities Summit. The Daily Camera talked with Jerde about the program, the summit and the opportunities for entrepreneurs. Read a transcript of the live chat here.
UCDHSC Professor Joins EPIX Board
EPIX Pharmaceuticals, Inc. on January 13 announced the appointments of Charles A. Dinarello, M.D., professor of medicine at the University of Colorado School of Medicine, and Edward Roberts, Ph.D., professor of translational chemistry and medicine at The Scripps Research Institute, to the company's Scientific Advisory Board (SAB). Dr. Dinarello is a world-leading expert on preclinical and clinical studies of inflammatory cytokines, particularly interleukin-1 and related cytokines.
CU-Boulder Graduate Student Wins AHA Award For Pediatric Cardiology Research
The American Heart Association has awarded its 2006 Outstanding Research Award in Pediatric Cardiology to a University of Colorado at Boulder graduate student. Rui Wang, who is working toward a doctoral degree in mechanical engineering, received the award for his development of an artificial right heart ventricle for use in pediatric patients. The cardiovascular assistive device, which is only about 2 square centimeters in size, could be surgically implanted to take over a child's missing right ventricle function.
Do you know of a recent award, new position or transition of interest to the CU tech community? Please send information to TTOnews@cu.edu.
TTO's Learning Laboratory: The Student Connection
TTO Introduces New Marketing Intern
The TTO hired Kathleen Monteferrante as Marketing Intern starting in January. In this role, she will research companies, create marketing materials, and conduct market research. Kathleen is pursuing a B.S. in Management and Marketing, and will graduate in spring 2008; after graduation, she plans to pursue a master’s degree in international business and eventually open up her own wedding and special events planning firm. Kathleen enjoys Pilates, sports, cooking, scrapbooking, shopping, and reading.
Spotlight On:
“Energy Autonomy” Talk and Book Signing with Herman Scheer
February 20, 2007, 1:30 pm, Old Main Auditorium, Boulder
The Colorado Renewable Energy Collaboratory welcomes Dr. Hermann Scheer, author of Energy Autonomy: The Economic, Social and Technological Case for Renewable Energy. Dr. Scheer is a member of the German Parliament, President of EUROSOLAR (the European Association for Renewable Energy) and General Chairman of the World Council for Renewable Energy. He will discuss and sign copies of his newest book at the Old Main Auditorium, University of Colorado at Boulder; this talk is free and open to the public. More info available at http://ei.colorado.edu.
Venture Capital In the Rockies 2007
February 20-22, 2007, Ritz-Carlton Hotel, Beaver Creek
Venture Capital in the Rockies is the largest and oldest capital conference in the Rocky Mountain region. The conference showcases the region’s most promising emerging growth companies for an audience of over 200 venture investors, CEOs, entrepreneurs and service professionals. CU-based presenting companies include Taligen Therapeutics, GlobeImmune, BaroFold, and ARCA Discovery.
2007 Sustainable Opportunities Summit
February 28 – March 2, 2007, Sheraton Four Points Southeast, Denver
Innovators in large and small companies have discovered that the global movement in sustainability opens up ways to make money and boost shareholder value. New products, new services, and new ways of doing business all represent opportunities for savvy companies. Join industry leaders at the second annual Sustainable Opportunities Summit. Corporate leaders will learn from innovators about their business strategies to improve practices, capture new markets, and communicate their activities in sustainability. Entrepreneurs will hear from experts in a range of fields, from green building to clean technology to natural foods, about new business opportunities, and meet potential collaborators. Investors will learn about industry trends, cutting-edge technologies, and new business models. This event is part of EntrepreneurshipWeek USA, sponsored by the Kauffman Foundation.
Transforming Energy and Markets: TEAM Reception
March 1, 2007, 5:30 pm, Sheraton Four Points Southeast, Denver
During the annual Sustainable Opportunities Summit (see above), mingle, network, and enjoy refreshments with members of the cleantech community – corporations, entrepreneurs, and investment community leaders. Learn more about cutting-edge energy research at CU and potential energy-related business opportunities. The reception is hosted by TEAM, the CU Energy Initiative’s outreach arm. Facilitated by the Deming Center for Entrepreneurship, TEAM works with the TTO, researchers at CU and NREL, and the private sector to identify opportunities for early engagement between researchers and businesses interested in energy research. Attendance is free, but pre-registration is required. For more information on attending this event, contact Alison Peters at alison.peters@colorado.edu or 303-666-7627.
Cleantech Innovation Challenge
March 1 – 2, 2007, Sheraton Four Points Southeast, Denver
The Robert H. and Beverly A. Deming Center for Entrepreneurship is pleased to announce the Cleantech Innovation Challenge. The inaugural event held in 2006, the Sustainable Venturing Business Plan Competition, has been renamed the Cleantech Innovation Challenge. This international event is designed to be the premier student competition showcasing emerging opportunities in the cleantech sector. A minimum of $25,000 in prize money will be awarded to the winning teams. The top-ranked team with a clean energy technology business plan will be invited to present its business plan at the 20th annual National Renewable Energy Laboratory’s (NREL) Industry Growth Forum in Fall 2007. The NREL forum is widely recognized as the premier investor venue for the clean energy industry. Eligibility, registration and info available online.
Re-examining Open Source and Community Development Conference
March 5, 2007, University of Colorado School of Law, Boulder
The Silicon Flatirons Program will present its second conference of the spring: RE-EXAMINING OPEN SOURCE AND COMMUNITY DEVELOPMENT. This Conference will revisit the rise and acceptance of Open Source Software throughout political and institutional entities, and the varying degrees of commitment and sincerity with which it has been adopted. Panels will discuss the legal risks associated with adopting an Open Source model, how the Open Source model may be incorporated outside the world of software, as well as the broader adoption of "Community Development" in the creation of new products and services inside and outside of the technological world. Information and registration available online.
CSIA C-Level @ A Mile High
March 8, 2007, 5:30 pm, INVESCO Field, Denver
Join more than 350 key C-Level technology executives, government and business leaders, venture capitalists, investment bankers and other influentials for an exclusive evening networking event hosted by the Colorado Software and Internet Association (CSIA). Connect with industry leaders and bolster support for Colorado's key educational initiatives. Attendees will mingle with IT stars at INVESCO Field's Fireside Lounge, and may bid on coveted one-on-one time with leading IT execs. Registration information is available online.
MBA 2007 Networking Night
March 8, 2007, 5:30 pm, Level 3 Communications, Broomfield
Please join industry professionals, CU Leeds MBA students, alumni, faculty and staff for an evening of reconnecting, networking, learning and just having a good time. Complementary food and beverages will be served. Information, registration, and directions available online. Please RSVP by March 2.
Rocky Mountain SBIR Conference
May 9-10, 2007, Renaissance Hotel, Denver
The Rocky Mountain SBIR Conference provides 2 full days of SBIR/STTR courses & information. Learn critical IP and marketing strategies, meet one-on-one with program managers, network with large corporate sponsors, and collaborate with industry clusters and neighboring state technologists. Get the latest details by emailing info@sbircolorado.org.
To have your event featured here, please send an email to TTOnews@cu.edu.
CU Resources
Bard Center Business Plan Competition
The 6th annual Bard Center Business Plan Competition seeks to promote the development of high caliber business plans, recognize the most outstanding plans with cash and in-kind awards from area businesses, and encourage the creation of new businesses. The specific objectives of the Business Plan Competition include the following:
- Support students, alumni and faculty researchers in their entrepreneurial endeavors
- Encourage the commercialization of promising ideas and the creation of new ventures
- Build bridges between the University of Colorado at Denver and Health Sciences Center, School of Business, Bard Center for Entrepreneurship, and the Denver area business community
- Be a catalyst for economic development and new business growth in Colorado
First prize is $10,000, with a total of $20,500 in awards. Presentation of business plans will by June 13, 2007. Note: application deadline is March 15 – more information is available at http://thunder1.cudenver.edu/bard/index.php or by emailing Alexander.E.Bracken@cudenver.edu.
Innovation in the News
Colorado Economic Development Remains Among the Strongest
Colorado not only has strong businesses, but it is well-positioned for future growth, according to a comprehensive assessment of state economies released January 18. The 20th Development Report Card for the States, released today by the nonprofit Corporation for Enterprise Development (CFED), listed Colorado on its Honor Roll for the second straight year for its overall economic development performance.
CSU Technology Transfer Creates Ties to Focused Technology Domains
Aiming to shave years off the process of moving technology from the lab to the marketplace, Colorado State University officials on Thursday unveiled a program to bridge the gap between academia and the business world. The idea is to create a series of "superclusters" - alliances of academic researchers, school staff and corporate experts - to collaborate and more quickly commercialize technology developed by school researchers. CSU's effort is similar to the structure used by the University of Colorado, said David Allen of CU’s technology transfer office.
Oil Company Commits $500M to Biofuels Research
University of California Berkeley and the University of Illinois have landed a $500 million research grant, sponsored by BP Plc., to fund an international biofuels research center. The California and Illinois schools effort edged out MIT and Purdue University for the grant. The decision Thursday came after months of lobbying effort to attract the 10-year grant. In June of 2005, BP announced it would establish a biosciences energy research laboratory in either the United States or the United Kingdom. The aim of what will be the BP Biosciences Institute is to convert organic matter to biofuel and create new biofuel components and high-yield energy molecule plants via plant science.
Texas Plans $3B Cancer Study Investment
Aiming to become a global leader in cancer research, Texas plans to invest $3 billion over the next decade in a bid to eradicate the disease, which kills more than a half-million Americans every year. Texas is home to the Lance Armstrong Foundation and the Susan G. Komen breast cancer foundation, two of the nation's premier cancer-research groups.
The project will combine their efforts with research conducted by private companies, state universities, medical schools and the elite University of Texas M.D. Anderson Cancer Center.
Hawai`i Governor Outlines Broad-based Innovation Strategy
With the opportunity presented by a $732M budget surplus, Governor Linda Lingle wants Hawai`i to shift its public investment philosophy away from land development and toward encouraging, nurturing and rewarding innovation, creativity, entrepreneurship and risk-taking. Most of Gov. Lingle's State of the State Address on Jan. 22 and her 56-page 2007 Initiatives booklet is dedicated to explaining how she wants the public sector to lead realignment of the state’s economy toward “one fueled by innovation and new ideas generated by our universities and a highly-trained workforce.”
California Stem Cell Institute Clears a Hurdle
California's voter-approved stem cell research institute cleared a roadblock Monday when a University of Wisconsin alumni group said it would not seek to collect licensing fees on discoveries made with institute grants. Proposition 71, passed in 2004, created the California Institute for Regenerative Medicine and all but promised taxpayers royalties in return for approving $3 billion in bonds for research. A move to collect fees out of any royalties would likely have led to a court battle. The Wisconsin Alumni Research Foundation claims sweeping patent rights to all embryonic stem cell lines in the United States because it contends that a University of Wisconsin researcher was the first to successfully isolate such cells.
Private Backers Chip In $3M For Washington State Life Sciences Discovery Fund
Washington State's Life Sciences Discovery Fund, an effort to channel more state resources toward research that could bolster the biotech industry, today announced a $3 million donation from five of the biggest names in corporate and private giving locally.
Amgen, Microsoft, Regence BlueShield, the Bill & Melinda Gates Foundation, and the Paul G. Allen Family Foundation chipped in on the first significant gift the fund has announced since it was created by the Legislature in 2005. The fund will hand out $350 million in tobacco settlement money over 10 years beginning in 2008.
Stem Cell Research Target of More State Dollars in Iowa
Less than two weeks after his inauguration, Iowa Gov. Chet Culver called for the state legislature to lift the state ban on embryonic stem cell research. The ban was first instituted in 2002. Gov. Culver made the announcement at the University of Iowa's Medical Education and Research Facility. He also announced that when he presents his budget to the legislature, he will include $12.5 million for the construction of Iowa's Center for Regenerative Medicine to be built at the university.
University of Cambridge (UK) Technology Transfer Changes
Cambridge Enterprise, the University of Cambridge’s knowledge and technology transfer service, has become a Limited Company. The new company, wholly owned by the University, is headed by Teri Willey as Chief Executive. The business plan for the new company calls for a market driven approach addressing internal (University academics) and external (parties interested in partnering to commercialize intellectual property) markets as well as an asset management approach to the growing portfolios of commercialization contracts and equity holdings.
University Tech Transfer Offices Come Under Fire
University technology transfer offices have been criticized for losing opportunities to commercialize products, with monetary and corporate hiccups commonly cited as reasons. Individuals who work within the offices say that increased patent litigation is to blame for their more stringent approval processes.
Read the response from John Fraser, President of AUTM (Association of University Technology Managers) here.
The Route From Research to Start-Up
Hartmut Neven came from Germany to the University of Southern California a decade ago to lead research efforts in computerized face and object recognition. The aim was to create a tool for the military and law enforcement agencies to identify enemies and suspects as well as for airlines and other companies to check passengers and visitors. With encouragement from the technology transfer program at USC, he formed a company named Eyematic Inc. It later became Neven Vision, with the aid of $200,000 in seed money from William Woodward, managing director of Anthem Venture Partners.
Scientists Fight for Research Funding
Since 2004, researchers looking for treatments for cancer, heart disease and other ailments have found it harder and harder to get NIH funding as the agency's budget has stagnated. This year's proposed NIH budget, according to a House Appropriations Committee spokesman, is $28.9 billion, just a 2.2 percent increase and less than the rate of inflation. The result is more researchers clamoring for a limited pool of money and more scientists - especially those just starting their careers - shut out of federal research dollars.
Poking Holes in the State Immunity Shield
A federal appeals court on Tuesday weakened the shield that public universities and other state entities have increasingly used in recent years to protect themselves from patent lawsuits in federal court. The decision by the U.S. Court of Appeals for the Federal Circuit involved a patent dispute between the University of Missouri and a private company in which the University asserted an 11th Amendment immunity from suit.
Amgen Wins Ruling on Patent for Enbrel Arthritis Drug
Amgen, the world's biggest biotechnology company, won an appeals court ruling that prevents an Israeli company from seeking royalties on Enbrel, the rheumatoid arthritis treatment. Israel Bio-Engineering Project (IBEP) sued Amgen and its marketing partner Wyeth claiming they infringed a U.S. patent that covers Enbrel. In Israel Bio-Engineering (IBEP) v. Amgen (Fed. Cir. 2007), the appeals court upheld a finding that Yeda Research and Development, which licenses inventions of the Weizmann Institute of Science in Israel, is at least a part owner of the patent, blocking a suit by IBEP. See a TTO analysis of implications for university IP.
VC Puts Green in 'Green' Building
Venture investors interested in clean technology are finding a home for their investments in environmentally sustainable construction materials and processes. In the last two quarters of 2006, investors including DFJ Element, NGEN Partners, Nth Power and Rockport Capital Partners have invested in companies that are looking to create more ecologically and economically efficient tools for the construction industry. Helping pull investors into the construction market are reports like the one from McGraw-Hill Construction and the National Association of Home Builders published in June. That study indicated that the residential green building marketplace is expected to boost its market share to between $19 billion and $38 billion by 2010, up from $7.4 billion in 2005.
Clean Energy Investments More Than Double in 2006
Venture capital and private equity investments in clean energy companies increased by 167 percent in 2006, according to investment analysts at New Energy Finance Limited. These clean energy investments increased from $2.7 billion in 2005 to $7.1 billion in 2006, driven mainly by a surge of investments in biofuels in the United States. Investments in biofuels more than quadrupled, increasing from $647 million in 2005 to $2.8 billion in 2006. In addition, investments in solar energy more than tripled, while wind power investments more than doubled. Investments in other clean energy technologies—including energy efficiency, fuel cells, hydrogen, smart power distribution, and carbon markets—grew by 74 percent. Read the New Energy Finance press release here (PDF file).
External Resources
Colorado VC Dollars Drop
Venture capital investment in Colorado during last year fell from the total funding in 2005, according to two reports released this week. One of those reports notes a drop-off of 5 percent; another says it sank 32 percent. But to each of the reporting firms, Colorado's 2006 was not that shabby at all. "2005 was a particularly extraordinary year," said Mike Schoenfeld, Ernst & Young LLP's venture capital advisory group leader for the Pacific/Southwest regions. "If you do some comparisons, (2006) was quite a healthy year."
Colorado Dealmakers Predict More M&A Activity in 2007
A record $3.8 trillion year in global mergers and acquisitions has Colorado dealmakers expecting increased merger activity in the first half of 2007, according to a new survey by Association for Corporate Growth (ACG) and Thomson Financial. 52% of survey respondents expect an increase in mergers and acquisitions, 43% predict the market staying the same, and only 5% percent foresee a slowdown. The ACG/Thomson DealMakers Survey polled 1,230 investment bankers, private equity professionals, corporate development professionals, as well as lawyers, accountants and other service providers involved in the deal economy in December 2006.
Growing The Nation's Biotech Sector: State Bioscience Initiatives 2006
This 2006 report from the Biotechnology Industry Association presents updated data, examines growth trends, and identifies metropolitan areas with the largest and most concentrated employment in bioscience subsectors. It also identifies current key trends in state and regional initiatives to support the biosciences. In the report, Boulder is identified an area with a significant stake in the Pharmaceuticals subsector, and Denver-Aurora is identified as an “emerging” region in this subsector. Other available reports (PDF format) include Regional Perspective 2006 (a more detailed examination of the biosciences at the local level) and Colorado Bioscience Initiatives 2006.
Managing the Effects of Nanotechnology
As nanotechnology moves from the realm of science fiction to the reality of new products and technologies, experts are starting to take a closer look at how nanotechnology can and should be regulated. A new study from the Woodrow Wilson Center’s Project on Emerging Nanotechnologies offers a useful guide to these debates. Access the 2006 report of the Woodrow Wilson Center Project on Emerging Nanotechnologies, Managing the Effects of Nanotechnology, by J. Clarence Davis (PDF file).
Democrats '07 Budget Targets Earmarks, Increases Research Funding
Less than one week before President Bush releases the Administration's budget request for fiscal year 2008, congressional Democratic leadership released its solution to the FY 2007 fiasco. As expected, earmarks have been stripped from the Joint Resolution covering $463 billion in spending, which covers most of the federal government as 11 FY07 funding bills remained unfinished when Republicans handed over control of both chambers of Congress. Earmarks had become a common funding mechanism for many university research programs and economic development related activities. On the positive side, the House Appropriations Committee says the joint resolution holds increases for Pell Grants, NIH, NSF, DOE, DOD, and National Institute of Standards and Technology (NIST) Innovation Programs.
The Democratization of R&D
An interesting working paper from researchers at the Federal Reserve Bank of Philadelphia examines a phenomenon they describe as the “democratization” of R&D spending. Before 1980, large incumbent firms had much higher rates of R&D intensity (R&D spending/sales) than did small firms and those looking to enter the same industry. Today, that ratio is often flipped, with small firms often surpassing the R&D intensity of larger firms. Access the 2006 working paper, “The Democratization of US Research and Development after 1980” by Robert M. Hunt and Leonard I. Nakamura (PDF file).
MIT Technology Review: Has Personalized Medicine Arrived?
It may have arrived for real this month with a largely bureaucratic announcement by a government agency. (Blog by Technology Review, published by Technology Review Inc., an independent media company owned by MIT. Technology Review aims to promote the understanding of emerging technologies and to analyze their commercial, social, and political impacts.)
Parting Quotes
“Energy is today’s version of the space race of the ‘60s and the technology race of the ‘80s and ‘90s. We have a head start because of our natural resources, our intellectual resources and our entrepreneurial spirit.”
-Colorado Governor Bill Ritter, State-of-the-State address
|